These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1063 related articles for article (PubMed ID: 10934650)
1. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650 [TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. Shen V; Birchman R; Wu DD; Lindsay R J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865 [TBL] [Abstract][Full Text] [Related]
3. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [TBL] [Abstract][Full Text] [Related]
4. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862 [TBL] [Abstract][Full Text] [Related]
5. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine. Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625 [TBL] [Abstract][Full Text] [Related]
6. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats. Lane NE; Thompson JM; Strewler GJ; Kinney JH J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502 [TBL] [Abstract][Full Text] [Related]
7. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345 [TBL] [Abstract][Full Text] [Related]
8. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model. Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776 [TBL] [Abstract][Full Text] [Related]
9. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845 [TBL] [Abstract][Full Text] [Related]
10. Effects of different dosages of parathyroid hormone-related protein 1-34 on the bone metabolism of the ovariectomized rat model of osteoporosis. Xu J; Rong H; Ji H; Wang D; Wang J; Zhang W; Zhang Y Calcif Tissue Int; 2013 Sep; 93(3):276-87. PubMed ID: 23807531 [TBL] [Abstract][Full Text] [Related]
11. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. Armamento-Villareal R; Ziambaras K; Abbasi-Jarhomi SH; Dimarogonas A; Halstead L; Fausto A; Avioli LV; Civitelli R J Bone Miner Res; 1997 Mar; 12(3):384-92. PubMed ID: 9076581 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats. Rhee Y; Won YY; Baek MH; Lim SK J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792 [TBL] [Abstract][Full Text] [Related]
13. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats. Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950 [TBL] [Abstract][Full Text] [Related]
14. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. Liu CC; Kalu DN J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827 [TBL] [Abstract][Full Text] [Related]
15. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity. Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311 [TBL] [Abstract][Full Text] [Related]
16. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755 [TBL] [Abstract][Full Text] [Related]
17. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats. Thomsen JS; Mosekilde LI; Gasser JA Bone; 1999 Nov; 25(5):561-9. PubMed ID: 10574576 [TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500 [TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34. Blind E; Raue F; Knappe V; Schroth J; Ziegler R Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983 [TBL] [Abstract][Full Text] [Related]
20. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. Zhou H; Shen V; Dempster DW; Lindsay R J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]